# Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

> PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, with publication-date metadata of 2026-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42400596-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-04
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42400596-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42400596-glucagon-v1.json
- Content SHA-256: `c241f2f1023798e459afa293dadbd61674097df52ac24119c8eac84b0c1007d5`

## Claims and source pins

### Headline

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research. ([`pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583`](#source-pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583))

### Summary

PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, with publication-date metadata of 2026-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583`](#source-pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583))

### Paragraph 1

PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, with publication-date metadata of 2026-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583`](#source-pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583`](#source-pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583))

## Sources

<a id="source-pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583"></a>
- **Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research. · retained source version 1:2026-07-04:current:ae5da0e1b583f6eadab7ada1dda34ad78f0af0a77979bc5810d792499e718e5a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42400596/) (`pubmed-observation-pmid-42400596-2026-07-04-ae5da0e1b583`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42400596-glucagon-v1.json SHA-256: c241f2f1023798e459afa293dadbd61674097df52ac24119c8eac84b0c1007d5.